摘要
目的:评价银杏达莫治疗急性特发性面神经麻痹的疗效。方法:62例急性特发性面神经麻痹患者随机分为银杏达莫组31例及对照组31例,分别应用银杏达莫25mL及丹参注射液20mL静脉滴注,每天1次,连续治疗14d,两组均同时使用相同剂量的泼尼松、抗病毒药及维生素B族治疗。治疗后1、3和4周采用House-Brackmann分级法进行疗效评估。结果:治疗后3周银杏达莫组患者痊愈率为48.38%(15/31),改善率为25.81%(8/31),总有效率74.19%;丹参组患者痊愈率为25.81%(8/31),改善率为16.13%(5/31),总有效率41.94%。治疗后4周,银杏达莫组痊愈率为74.19%(23/31),改善率为19.35%(6/31),总有效率93.55%;丹参组痊愈率为45.16%(14/31),改善率为22.58%(7/31),总有效率67.74%。两组间疗效差异有统计学意义(P<0.05)。结论:银杏达莫治疗急性特发性面神经麻痹的疗效好于丹参。
Aim： To evaluate the effect of Yinxingdamo injection on the acute idiopathic facial palsy. Methods： 62 patients diagnosed as acute idiopathic facial palsy were randomly assigned to Yinxingdamo injection group （n=31） used Yinxingdamo 25 mL per day, and comparison group （n=31） used Danshen 20 mL per day separately for fourteen days. The same dose of prednisone, antivirus drug and vitamin B were used in each group. House-Brackmann facial nerve grading system was used to evaluate the outcome of treatments at the time of 1 week, 3 weeks and 4 weeks. Results： Fifteen patients（48.38 %） recovered completely in Yinxingdamo group comparing with 8 patients （25.80 %） in Danshen group （P 〈0.05） after 3 weeks treatment, and 23 patients （74.19 %） recovered completely in Yinxingdamo group comparing with 14 patients （45.16 %） in Danshen group （P〈0.05） at the end of 4 weeks. Conclusion ： Yinxingdamo injection is superior to Danshen injection in treating acute idiopathic facial palsy.
出处
《中国临床神经科学》
2008年第2期175-178,共4页
Chinese Journal of Clinical Neurosciences
